Evaluating the safety of high-altitude travel in patients with adult congenital heart disease

Congenital Heart Disease

Volumn 5, Issue 3, 2010, Pages 220-232

  Luks, Andrew M ^a   Stout, Karen ^b   Swenson, Erik R ^a  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acute mountain sickness; Congenital heart disease; High altitude; High altitude cerebral edema; High altitude pulmonary edema; Hypoxia

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; NIFEDIPINE; SALMETEROL; SILDENAFIL; TADALAFIL;

ALTITUDE DISEASE; ARTICLE; BRAIN EDEMA; CARDIOPULMONARY FUNCTION; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONGENITAL HEART DISEASE; DISEASE PREDISPOSITION; EXERCISE; HEALTH STATUS; HEART RIGHT LEFT SHUNT; HIGH ALTITUDE CEREBRAL EDEMA; HIGH ALTITUDE PULMONARY EDEMA; HUMAN; HYPERBARIC OXYGEN; HYPERTENSION; HYPOXEMIA; LUNG CAPACITY; LUNG EDEMA; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; ACCLIMATIZATION; ADULT; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; CARDIOVASCULAR SYSTEM; COMPLICATION; CONGENITAL HEART MALFORMATION; EVIDENCE BASED MEDICINE; LUNG; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; TRAVEL;

ACCLIMATIZATION; ADULT; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; CARDIOVASCULAR SYSTEM; EVIDENCE-BASED MEDICINE; HEART DEFECTS, CONGENITAL; HUMANS; LUNG; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TRAVEL;

EID: 77954130280     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2010.00415.x     Document Type: Article

References (81)

1. Warnes CA, Liberthson R, Danielson GK. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001, 37:1170-1175.
2. West JB, Lahiri S, Maret KH, Peters RM, Pizzo CJ. Barometric pressures at extreme altitudes on Mt. Everest: physiological significance. J Appl Physiol. 1983, 54:1188-1194.
3. Kontos HA, Levasseur JE, Richardson DW, Mauck HP, Patterson JL. Comparative circulatory responses to systemic hypoxia in man and in unanesthetized dog. J Appl Physiol. 1967, 23:381-386.
4. Vogel JA, Harris CW. Cardiopulmonary responses of resting man during early exposure to high altitude. J Appl Physiol. 1967, 22:1124-1128.
5. Reeves JT, Groves BM, Sutton JR. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol. 1987, 63:531-539.
6. Kjaergaard J, Snyder EM, Hassager C, Olson TP, Oh JK, Johnson BD. The effect of 18 h of simulated high altitude on left ventricular function. Eur J Appl Physiol. 2006, 98:411-418.
7. Bernheim AM, Kiencke S, Fischler M. Acute changes in pulmonary artery pressures due to exercise and exposure to high altitude do not cause left ventricular diastolic dysfunction. Chest. 2007, 132:380-387.
8. Somers VK, Mark AL, Abboud FM. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension. 1988, 11:608-612.
9. D'Este D, Mantovan R, Martino A. The behavior of the arterial pressure at rest and under exertion in normotensive and hypertensive subjects exposed to acute hypoxia at a median altitude. G Ital Cardiol. 1991, 21:643-649.
10. Roach RC, Houston CS, Honigman B. How well do older persons tolerate moderate altitude? West J Med. 1995, 162:32-36.
11. Palatini P, Businaro R, Berton G. Effects of low altitude exposure on 24-hour blood pressure and adrenergic activity. Am J Cardiol. 1989, 64:1379-1382.
12. Luks AM. Should travelers with hypertension adjust their medications when traveling to high altitude? High Alt Med Biol. 2009, 10:11-15.
13. Talbot NP, Balanos GM, Dorrington KL, Robbins PA. Two temporal components within the human pulmonary vascular response to approximately 2 h of isocapnic hypoxia. J Appl Physiol. 2005, 98:1125-1139.
14. Reeves JT, Stenmark KR. The pulmonary circulation at high altitude. High Altitude: An Exploration of Human Adaptation 2001, 293-342. Hornbein TF, Schoene RB. In, eds., New York, Marcel Dekker, Inc
15. Grunig E, Mereles D, Hildebrandt W. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol. 2000, 35:980-987.
16. Dehnert C, Grunig E, Mereles D, von Lennep N, Bartsch P. Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude. Eur Respir J. 2005, 25:545-551.
17. Reeves JT, Wagner WWJ, McMurtry IF, Grover RF. Physiological effects of high altitude on the pulmonary circulation. International Review of Physiology: Environmental Physiology III 1979, 289-310. Robertshaw D, In, ed., Baltimore, Md, University Park Press
18. Pugh LG, Gill MB, Lahiri S, Milledge JS, Ward MP, West JB. Muscular exercise at great altitudes. J Appl Physiol. 1964, 19:431-440.
19. West JB, Boyer SJ, Graber DJ. Maximal exercise at extreme altitudes on Mount Everest. J Appl Physiol. 1983, 55:688-698.
20. Sutton JR, Reeves JT, Wagner PD. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol. 1988, 64:1309-1321.
21. Groves BM, Reeves JT, Sutton JR. Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol. 1987, 63:521-530.
22. Gale GE, Torre-Bueno JR, Moon RE, Saltzman HA, Wagner PD. Ventilation-perfusion inequality in normal humans during exercise at sea level and simulated altitude. J Appl Physiol. 1985, 58:978-988.
23. Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001, 345:107-114.
24. Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol. 2004, 5:136-146.
25. Bartsch P, Mairbaurl H, Maggiorini M, Swenson ER. Physiological aspects of high-altitude pulmonary edema. J Appl Physiol. 2005, 98:1101-1110.
26. Schoene RB. Illnesses at high altitude. Chest. 2008, 134:402-416.
27. Hackett PH, Rennie D. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 1976, 2:1149-1155.
28. Honigman B, Theis MK, Koziol-McLain J. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993, 118:587-592.
29. Bartsch P, Maggiorini M, Mairbaurl H, Vock P, Swenson ER. Pulmonary extravascular fluid accumulation in climbers. Lancet. 2002, 360:571. author reply 71-72
30. Schoene RB, Hultgren HN, Swenson ER. High-altitude pulmonary edema. High Altitude: An Exploration of Human Adaptation 2001, 778-814. Hornbein TF, Schoene RB, In, eds., New York, Marcel Dekker
31. Forwand SA, Landowne M, Follansbee JN, Hansen JE. Effect of acetazolamide on acute mountain sickness. N Engl J Med. 1968, 279:839-845.
32. Ellsworth AJ, Meyer EF, Larson EB. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. West J Med. 1991, 154:289-293.
33. Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991, 325:1284-1289.
34. Maggiorini M, Brunner-La Rocca HP, Peth S. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med. 2006, 145:497-506.
35. Kasic JF, Yaron M, Nicholas RA, Lickteig JA, Roach R. Treatment of acute mountain sickness: hyperbaric versus oxygen therapy. Ann Emerg Med. 1991, 20:1109-1112.
36. Luks AM. Do we have a " best practice" for treating high altitude pulmonary edema? High Alt Med Biol. 2008, 9:111-114.
37. Luks AM, Swenson ER. Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. Chest. 2008, 133:744-755.
38. Hultgren HN, Lopez CE, Lundberg E, Miller H. Physiologic studies of pulmonary edema at high altitude. Circulation. 1964, 29:393-408.
39. Maggiorini M, Melot C, Pierre S. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation. 2001, 103:2078-2083.
40. Swenson ER, Maggiorini M, Mongovin S. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA. 2002, 287:2228-2235.
41. Torrington KG. Recurrent high-altitude illness associated with right pulmonary artery occlusion from granulomatous mediastinitis. Chest. 1989, 96:1422-1424.
42. Nakagawa S, Kubo K, Koizumi T, Kobayashi T, Sekiguchi M. High-altitude pulmonary edema with pulmonary thromboembolism. Chest. 1993, 103:948-950.
43. Naeije R, De Backer D, Vachiery JL, De Vuyst P. High-altitude pulmonary edema with primary pulmonary hypertension. Chest. 1996, 110:286-289.
44. Hackett PH, Creagh CE, Grover RF. High-altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med. 1980, 302:1070-1073.
45. Rios B, Driscoll DJ, McNamara DG. High-altitude pulmonary edema with absent right pulmonary artery. Pediatrics. 1985, 75:314-317.
46. Durmowicz AG. Pulmonary edema in 6 children with Down syndrome during travel to moderate altitudes. Pediatrics. 2001, 108:443-447.
47. Durmowicz AG, Noordeweir E, Nicholas R, Reeves JT. Inflammatory processes may predispose children to high-altitude pulmonary edema. J Pediatr. 1997, 130:838-840.
48. Das BB, Wolfe RR, Chan KC, Larsen GL, Reeves JT, Ivy D. High-altitude pulmonary edema in children with underlying cardiopulmonary disorders and pulmonary hypertension living at altitude. Arch Pediatr Adolesc Med. 2004, 158:1170-1176.
49. Toff NJ. Hazards of air travel for the obese: Miss Pickwick and the Boeing 747. J R Coll Physicians Lond. 1993, 27:375-376.
50. Noble JS, Davidson JA. Cor pulmonale presenting in a patient with congenital kyphoscoliosis following intercontinental air travel. Anaesthesia. 1999, 54:361-363.
51. Hosseinpour AR, Sudarshan C, Davies P, Nashef SA, Barron DJ, Brawn WJ. The impact of altitude on early outcome following the Fontan operation. J Cardiothorac Surg. 2006, 1:34.
52. Day RW, Orsmond GS, Sturtevant JE, Hawkins JA, Doty DB, McGough EC. Early and intermediate results of the Fontan procedure at moderately high altitude. Ann Thorac Surg. 1994, 57:170-176.
53. Edelman NH, Lahiri S, Braudo L, Cherniack NS, Fishman AP. The blunted ventilatory response to hypoxia in cyanotic congenital heart disease. N Engl J Med. 1970, 282:405-411.
54. Chua TP, Iserin L, Somerville J, Coats AJ. Effects of chronic hypoxemia on chemosensitivity in patients with univentricular heart. J Am Coll Cardiol. 1997, 30:1827-1834.
55. Moore LG, Harrison GL, McCullough RE. Low acute hypoxic ventilatory response and hypoxic depression in acute altitude sickness. J Appl Physiol. 1986, 60:1407-1412.
56. Hohenhaus E, Paul A, McCullough RE, Kucherer H, Bartsch P. Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema. Eur Respir J. 1995, 8:1825-1833.
57. Matsuzawa Y, Fujimoto K, Kobayashi T. Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol. 1989, 66:1152-1157.
58. Milledge JS, Thomas PS, Beeley JM, English JS. Hypoxic ventilatory response and acute mountain sickness. Eur Respir J. 1988, 1:948-951.
59. Bartsch P, Swenson ER, Paul A, Julg B, Hohenhaus E. Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness. High Alt Med Biol. 2002, 3:361-376.
60. Blesa MI, Lahiri S, Rashkind WJ, Fishman AP. Normalization of the blunted ventilatory response to acute hypoxia in congenital cyanotic heart disease. N Engl J Med. 1977, 296:237-241.
61. Sorensen SC, Severinghaus JW. Respiratory insensitivity to acute hypoxia persisting after correction of tetralogy of Fallot. J Appl Physiol. 1968, 25:221-223.
62. Paridon SM, Sullivan NM, Schneider J, Pinsky WW. Cardiopulmonary performance at rest and exercise after repair of total anomalous pulmonary venous connection. Am J Cardiol. 1993, 72:1444-1447.
63. McBride MG, Kirshbom PM, Gaynor JW. Late cardiopulmonary and musculoskeletal exercise performance after repair for total anomalous pulmonary venous connection during infancy. J Thorac Cardiovasc Surg. 2007, 133:1533-1539.
64. Harinck E, Hutter PA, Hoorntje TM. Air travel and adults with cyanotic congenital heart disease. Circulation. 1996, 93:272-276.
65. Burtscher M, Flatz M, Faulhaber M. Prediction of susceptibility to acute mountain sickness by SaO2 values during short-term exposure to hypoxia. High Alt Med Biol. 2004, 5:335-340.
66. Roach RC, Greene ER, Schoene RB, Hackett PH. Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med. 1998, 69:1182-1185.
67. Allemann Y, Hutter D, Lipp E. Patent foramen ovale and high-altitude pulmonary edema. JAMA. 2006, 296:2954-2958.
68. Berman W, Wood SC, Yabek SM, Dillon T, Fripp RR, Burstein R. Systemic oxygen transport in patients with congenital heart disease. Circulation. 1987, 75:360-368.
69. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation. 1993, 87:1954-1959.
70. Rosenthal A, Nathan DG, Marty AT, Button LN, Miettinen OS, Nadas AS. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation. 1970, 42:297-308.
71. Broberg CS, Uebing A, Cuomo L, Thein SL, Papadopoulos MG, Gatzoulis MA. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart. 2007, 93:1599-1603.
72. Swenson ER. Renal function and fluid homeostasis. High Altitude: An Exploration of Human Adaptation 2001, 525-568. Hornbein TFSchoene RB. In, eds., New York, Marcel Dekker
73. Eldridge F, Salzer J. Effect of respiratory alkalosis on blood lactate and pyruvate in humans. J Appl Physiol. 1967, 22:461-468.
74. Christensen CC, Ryg M, Refvem OK, Skjonsberg OH. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2438 m (8000 ft) altitude. Eur Respir J. 2000, 15:635-639.
75. Seccombe LM, Kelly PT, Wong CK, Rogers PG, Lim S, Peters MJ. Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease. Thorax. 2004, 59:966-970.
76. Christensen CC, Ryg MS, Refvem OK, Skjonsberg OH. Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease. Eur Respir J. 2002, 20:300-305.
77. Mestry N, Thirumaran M, Tuggey JM, Macdonald W, Elliott MW. Hypoxic challenge flight assessments in patients with severe chest wall deformity or neuromuscular disease at risk for nocturnal hypoventilation. Thorax. 2009, 64:532-534.
78. Fischer R, Lang SM, Bruckner K. Lung function in adults with cystic fibrosis at altitude: impact on air travel. Eur Respir J. 2005, 25:718-724.
79. Garcia JA, McMinn SB, Zuckerman JH, Fixler DE, Levine BD. The role of the right ventricle during hypobaric hypoxic exercise: insights from patients after the Fontan operation. Med Sci Sports Exerc. 1999, 31:269-276.
80. Dine CJ, Kreider ME. Hypoxia altitude simulation test. Chest. 2008, 133:1002-1005.
81. Swenson ER, Teppema LJ. Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story. J Appl Physiol. 2007, 102:1305-1307.